Outdoor Ukulele Makes New All Weather Instruments for Traveling

Bend, Oregon (PRWEB) April 04, 2016

Outdoor Ukulele begins manufacturing American made composite polycarbonate instruments that withstand the rigors of traveling. They've been played in the Arctic Ocean, paddled down the Amazon River, and hiked both the Appalachian and Pacific Crest Trails. Their Soprano and Tenor ukuleles use high-performance tone resins that match the acoustic qualities of most wood instruments with unparalleled durability and temperature range.

Handcrafted wood ukuleles made from tone woods like Mahogany, Spruce, or Koa are cherished for their brilliant acoustics and beauty. But what if you want to play your wood ukulele in the park on a warm and humid summer afternoon, or in the mountains on a cold and dry winter morning? Luthiers recommend keeping your instrument in a controlled environment with a temperature range of 65°F to 75°F (18°C to 24°C), and a relative humidity range of 45% to 55%. Any deviation from these parameters could cause permanent damage to string action, cracks in the body, and glue joint separation.

Outdoor Ukulele injection molds the two component monocoque instruments from 15% glass fiber filled Polycarbonate with a temperature range of -40°F to 250°F (-40° C to 120° C). The addition of glass fibers greatly increase strength, enhance acoustics, and create a natural grain structure which compliments the translucent Bottle Brown and Bottle Green colors. The compact Soprano sells for $95 and the larger Tenor sells for $145.

Outdoor Ukulele is a family owned and operated company based in Bend, Oregon. Visit http://www.outdoorukulele.com for more information.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13312949.htm

You May Also Be Interested In

• IBFD Travel Grant Opens Doors for International Tax Law Researchers
• TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2024
• PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers